Found: 19
Select item for more details and to access through your institution.
Contribution of Metabolomics to the Understanding of NAFLD and NASH Syndromes: A Systematic Review.
- Published in:
- Metabolites (2218-1989), 2021, v. 11, n. 10, p. 694, doi. 10.3390/metabo11100694
- By:
- Publication type:
- Article
Effectiveness and Safety of Biological Therapies in Very Severe Plaque Psoriasis: A Real-Life Retrospective Study.
- Published in:
- Journal of Personalized Medicine, 2024, v. 14, n. 2, p. 186, doi. 10.3390/jpm14020186
- By:
- Publication type:
- Article
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis).
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1341708
- By:
- Publication type:
- Article
Monkeypox infection with perianal lesions, fever, and lymphadenopathy.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 3, p. e142, doi. 10.1111/ijd.16437
- By:
- Publication type:
- Article
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks.
- Published in:
- Dermatology Reports, 2024, v. 16, n. 1, p. 16, doi. 10.4081/dr.2023.9722
- By:
- Publication type:
- Article
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study.
- Published in:
- Dermatology Reports, 2023, v. 15, n. 3, p. 1, doi. 10.4081/dr.2023.9692
- By:
- Publication type:
- Article
Sub‐erythrodermic psoriasis successfully treated with bimekizumab: A case report.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15952
- By:
- Publication type:
- Article
Effectiveness and safety of risankizumab in HIV patients with psoriasis: A case series.
- Published in:
- International Journal of STD & AIDS, 2024, v. 35, n. 1, p. 67, doi. 10.1177/09564624231199510
- By:
- Publication type:
- Article
Real‐life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104‐week multicenter retrospective study – IL PSO (ITALIAN LANDSCAPE PSORIASIS).
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 5, p. 1017, doi. 10.1111/jdv.18913
- By:
- Publication type:
- Article
Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis).
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 1, p. 93, doi. 10.1111/jdv.18594
- By:
- Publication type:
- Article
Effectiveness of ixekizumab for the treatment of moderate‐to‐severe plaque psoriasis with involvement of difficult‐to‐treat areas: A 52‐week multicenter retrospective study.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 6, p. 839, doi. 10.1111/1346-8138.17115
- By:
- Publication type:
- Article
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS).
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 495, doi. 10.3390/jcm13020495
- By:
- Publication type:
- Article
Safety of Interleukin Inhibitors in Patients with Plaque Psoriasis and Neoplasm: A Retrospective Study from Two Referral Centers.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 10, p. 807, doi. 10.1007/s40261-023-01306-2
- By:
- Publication type:
- Article
Intra-Class Switch Among IL-23 Inhibitors for Plaque Psoriasis: Is It Worth It?
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 5, p. 365, doi. 10.1007/s40261-023-01271-w
- By:
- Publication type:
- Article
Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review.
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2024, v. 17, p. 593, doi. 10.2147/CCID.S329442
- By:
- Publication type:
- Article
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis).
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 6, p. 1649, doi. 10.1007/s13555-024-01182-4
- By:
- Publication type:
- Article
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 4, p. 919, doi. 10.1007/s13555-024-01135-x
- By:
- Publication type:
- Article
Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 2, p. 651, doi. 10.1007/s13555-022-00882-z
- By:
- Publication type:
- Article
Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 10, p. 2309, doi. 10.1007/s13555-022-00795-x
- By:
- Publication type:
- Article